Neonatal plasma polarizes TLR4-mediated cytokine responses towards low IL-12p70 and high IL-10 production via distinct factors

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Belderbos, Mirjam E ^a   Levy, Ofer ^b   Stalpers, Femke ^a   Kimpen, Jan L ^a   Meyaard, Linde ^a   Bont, Louis ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; LIPOPROTEIN RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8; VITAMIN D; IL10 PROTEIN, HUMAN; INTERLEUKIN 12; MYD88 PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TLR8 PROTEIN, HUMAN;

ADULT; ARTICLE; CYTOKINE PRODUCTION; HUMAN; INFANT; MONOCYTE; NEWBORN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN DEPLETION; UMBILICAL CORD BLOOD; BIOSYNTHESIS; CLINICAL OBSERVATION; CLINICAL STUDY; CYTOLOGY; DIAGNOSIS; DRUG POTENTIATION; FEMALE; FETUS BLOOD; MALE; METABOLISM; MONONUCLEAR CELL; PLASMA;

ADULT; ANTIGENS, CD14; DINOPROSTONE; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INTERLEUKIN-10; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MALE; MYELOID DIFFERENTIATION FACTOR 88; PLASMA; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 8; VITAMIN D;

EID: 84858590043     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033419     Document Type: Article

References (42)

1. Akira S, Uematsu S, Takeuchi O, (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
2. Akira S, Takeda K, (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
3. Marshak-Rothstein A, (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6: 823-835.
4. Levy O, (2007) Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7: 379-390.
5. Levy O, (2005) Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J Endotoxin Res 11: 113-116.
6. Nguyen M, Leuridan E, Zhang T, De Wit D, Willems F, et al. (2010) Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS One 5: e10407.
7. Yerkovich ST, Wikstrom ME, Suriyaarachchi D, Prescott SL, Upham JW, et al. (2007) Postnatal development of monocyte cytokine responses to bacterial lipopolysaccharide. Pediatr Res 62: 547-552.
8. Maldonado Y, Nizet V, Klein J, Remington J, Wilson CB, (2001) Current concepts of infections of the fetus and newborn infant. In: Klein J, Remington J, editors. Infectious Diseases of the Fetus and Newborn Infant Philadelphia Saunders pp. 2-19.
9. Levy O, Coughlin M, Cronstein BN, Roy RM, Desai A, et al. (2006) The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J Immunol 177: 1956-1966.
10. Lappalainen M, Roponen M, Pekkanen J, Huttunen K, Hirvonen MR, (2009) Maturation of cytokine-producing capacity from birth to 1 yr of age. Pediatr Allergy Immunol 20: 714-725.
11. Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, et al. (2009) Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 183: 7150-7160.
12. Forster-Waldl E, Sadeghi K, Tamandl D, Gerhold B, Hallwirth U, et al. (2005) Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr Res 58: 121-124.
13. Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, et al. (2004) Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 173: 4627-4634.
14. Belderbos ME, van Bleek GM, Levy O, Blanken MO, Houben ML, et al. (2009) Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin Immunol 133: 228-237.
15. Lee SM, Suen Y, Chang L, Bruner V, Qian J, et al. (1996) Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 88: 945-954.
16. Levy O, Suter EE, Miller RL, Wessels MR, (2006) Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood 108: 1284-1290.
17. Goriely S, Van Lint C, Dadkhah R, Libin M, De Wit D, et al. (2004) A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J Exp Med 199: 1011-1016.
18. Goriely S, Molle C, Nguyen M, Albarani V, Haddou NO, et al. (2006) Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood 107: 1078-1084.
19. Jansen K, Blimkie D, Furlong J, Hajjar A, Rein-Weston A, et al. (2008) Polychromatic flow cytometric high-throughput assay to analyze the innate immune response to Toll-like receptor stimulation. J Immunol Methods 336: 183-192.
20. Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, et al. (2008) MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry A 73: 926-930.
21. Belderbos ME, Houben ML, Wilbrink B, Lentjes E, Bloemen EM, et al. (2011) Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics 127: e1513-e1520.
22. Szeles L, Keresztes G, Torocsik D, Balajthy Z, Krenacs L, et al. (2009) 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol 182: 2074-2083.
23. Kalinski P, Vieira PL, Schuitemaker JH, de Jong EC, Kapsenberg ML, (2001) Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97: 3466-3469.
24. Mitchell MD, Lucas A, Etches PC, Brunt JD, Turnbull AC, (1978) Plasma prostaglandin levels during early neonatal life following term and pre-term delivery. Prostaglandins 16: 319-326.
25. Kitchens RL, Thompson PA, (2005) Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 11: 225-229.
26. Goriely S, Vincart B, Stordeur P, Vekemans J, Willems F, et al. (2001) Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 166: 2141-2146.
27. Al-Hertani W, Yan SR, Byers DM, Bortolussi R, (2007) Human newborn polymorphonuclear neutrophils exhibit decreased levels of MyD88 and attenuated p38 phosphorylation in response to lipopolysaccharide. Clin Invest Med 30: E44-E53.
28. Ishida M, Shima M, Seino Y, (1988) 1,25(OH)2D and 24,25(OH)2D production in the developing kidney. Pediatr Nephrol 2: 166-170.
29. Hasko G, Kuhel DG, Chen JF, Schwarzschild MA, Deitch EA, et al. (2000) Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J 14: 2065-2074.
30. Hasko G, Kuhel DG, Salzman AL, Szabo C, (2000) ATP suppression of interleukin-12 and tumour necrosis factor-alpha release from macrophages. Br J Pharmacol 129: 909-914.
31. Loscher CE, Draper E, Leavy O, Kelleher D, Mills KH, et al. (2005) Conjugated linoleic acid suppresses NF-kappa B activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J Immunol 175: 4990-4998.
32. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB, (2009) Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol 10: 1081-1088.
33. Waggoner SN, Cruise MW, Kassel R, Hahn YS, (2005) C1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J Immunol 175: 4706-4714.
34. Wittmann M, Zwirner J, Larsson VA, Kirchhoff K, Begemann G, et al. (1999) C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. J Immunol 162: 6763-6769.
35. Sohn JH, Bora PS, Suk HJ, Molina H, Kaplan HJ, et al. (2003) Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat Med 9: 206-212.
36. Okazaki N, Hazeki K, Izumi T, Nigorikawa K, Hazeki O, (2011) C5a controls TLR-induced IL-10 and IL-12 production independent of phosphoinositide 3-kinase. J Biochem 149: 265-274.
37. Castellano G, Woltman AM, Schlagwein N, Xu W, Schena FP, et al. (2007) Immune modulation of human dendritic cells by complement. Eur J Immunol 37: 2803-2811.
38. Firth MA, Shewen PE, Hodgins DC, (2005) Passive and active components of neonatal innate immune defenses. Anim Health Res Rev 6: 143-158.
39. Wynn JL, Levy O, (2010) Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol 37: 307-337.
40. Chavez-Sanchez L, Chavez-Rueda K, Legorreta-Haquet MV, Zenteno E, Ledesma-Soto Y, et al. (2010) The activation of CD14, TLR4, and TLR2 by mmLDL induces IL-1beta, IL-6, and IL-10 secretion in human monocytes and macrophages. Lipids Health Dis 9: 117.
41. Wang X, Allen C, Ballow M, (2007) Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-alpha from LPS-stimulated monocytes/macrophages. J Clin Immunol 27: 193-200.
42. Le Moine O, Stordeur P, Schandené L, Marchant A, De Groote D, (1996) Adenosine enhances IL-10 secretion by human monocytes. J Immunol 156: 4408-4414.